Amantadine combined with pegylated IFNα2b and ribavirin has also shown efficacy in the treatment of chronic hepatitis C (measured as a sustained virological response—SVR) [14,15], which was higher in drug-naïve than in non-responders to IFNα2b [16]. The gene discussed is IFNA2; the disease is chronic hepatitis C virus infection.